AhR Ligand - FICZ

6-Formylindolo[3,2-b]carbazole; AhR Agonist

SPECIFICATIONS

Specifications

Source
Synthetic
Synonyms
6-Formylindolo[3,2-b]carbazole
CAS number
172922-91-7
Chemical formula

C19H12N2O

Molecular weight
284.31 g/mol
Working concentration

50 ng/ml (0.18 µM) to 5 μg/ml (18 μM)

Purity
≥ 95% (UHPLC)
Solubility

10 mg/ml (37.17 mM) in DMSO

Appearance (form)
Lyophilized powder
Appearance (color)
White
Tested applications

AhR activation using HepG2-Lucia™ AhR and HT29-Lucia™ AhR reporter cellular assays

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    FICZ
  • Cat code: 
    tlrl-ficz
  • Quantity: 
    1 mg

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

AhR Background

The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcriptional factor widely expressed in barrier tissues [2]. AhR plays a key role in gut-microbiota and host immune homeostasis [2]. Besides xenobiotics, including the prototypic AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a variety of dietary-derived AhR ligands have been identified, many of which are byproducts of tryptophan metabolism [2].

Inactive AhR resides inactive in the cytoplasm within protein complex consisting of Hsp90:XAP2:p23:Src. The AhR canonical genomic signaling pathway occurs as follows: upon ligand binding, the complex undergoes conformational changes and partly translocates into the nucleus. AhR heterodimerizes with AhR nuclear translocator (ARNT) before binding to dioxin response elements (DREs) in the upstream regulatory regions of AhR target genes, such as the cytochrome P450-dependent monooxygenase Cyp1a1 or the AhR repressor (AhRR) [2].

Given the pleiotropic and highly context-dependent nature of AHR signaling, further studies are essential to fully elucidate its complex biological functions and therapeutic potential across a broad range of diseases, including cancer, inflammatory and autoimmune disorders [1-2]. For example, disruptions in AhR signaling have been shown to be involved in the development of diseases such as inflammatory bowel disease (IBD) and atopic dermatitis (AD) [2].

 

References

1. Karasová M, et al., 2022. Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells. Cancers (Basel). 14(17):4245
2. Coumoul X, et al., 2026. The aryl hydrocarbon receptor: structure, signaling, physiology and pathology. Signal Transduct Target Ther.11(1):20.

DOCUMENTS

Documents

FICZ

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?